Skip to main content
. 2017 Jan 11;3(2):91–95. doi: 10.1016/j.ijwd.2016.11.003

Table 1.

Summary of case features of localized cutaneous nodular amyloidosis in limited systemic sclerosis.

Reference Age, yrs Sex Length of LSSc Diagnosis (yrs) Location of LCNA yrs nodules present before presentation, progression LCNA Treatments Tried, Results LSSc Therapy Negative systemic workup Positive systemic workup Follow up (yrs)
Summers and Kendrick, 2008 61 Female 1 left shin unknown, increasing in number and extending to bilateral lower extremities over the next 3 years pulsed dye laser every 6 weeks, improved tenderness of lesions unknown CBC, glucose, serum-free light chains, paraproteinemia, SPEP/UPEP, RFT, echo, chest CT, skeletal survey, bone marrow biopsy elevated LFT secondary to fatty liver 8
Shiman et al. 2010 83 Female 0 bilateral lower extremities 25, increasing in size and number over this time unknown unknown unknown unknown unknown
Damian et al. 2010 61 Male 10 bilateral lower extremities 1.5 patient declined therapy unknown CBC, serum free light chains, serum immunoelectrophroretogram, SPEP/UPEP, UA, LFT, RFT, TFT, echo, chest CT, abdomen CT, pelvis CT, abdominal biopsy, rectal biopsy none unknown
Current study 71 Female 4 left shin 1 monthly intralesional triamcinolone (10 mg/ml) injections over 3 months, modest improvement omeprazole for esophageal dysmotility CBC, BMP, SPEP/UPEP, PFT, echo none 1
Current study 58 Female 4 bilateral lower extremities 1.5 monthly intralesional triamcinolone (10 mg/ml) injections over 4 months, modest improvement unknown echo, bone marrow biopsy serum immunofixation electrophoresis, lung nodules of nodular amyloidosis 9, diagnosed with Sjögren Syndrome at year 5
Current study 70 Female 22 right shin 4-5, enlarging over this time surgically debulked, resolution and improved tenderness amlodipine for Raynaud phenomenon, omeprazole for esophageal dysmotility, physical therapy for sclerodactyly BMP, SPEP/UPEP, PFT, echo leukopenia, subclinical hypothyroidism 1

BMP: basic metabolic panel; CBC: complete blood count; CT: computed tomography; LCNA: localized cutaneous nodular amyloidosis; LFT: liver function tests; LSSc: limited systemic sclerosis; PFT: pulmonary function tests; RFT: renal function tests; SPEP/UPEP: serum protein electrophoresis/urine protein electrophoresis; TFT: thyroid function tests; echo: echocardiogram; UA: urinalysis.